Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation.
Piede N, Bremm M, Farken A, Pfeffermann LM, Cappel C, Bonig H, Fingerhut T, Puth L, Vogelsang K, Peinelt A, Marschalek R, Müller M, Bader P, Kuçi Z, Kuçi S, Huenecke S. Piede N, et al. Among authors: huenecke s. Cells. 2023 Mar 9;12(6):850. doi: 10.3390/cells12060850. Cells. 2023. PMID: 36980191 Free PMC article.
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.
Kuçi S, Kuçi Z, Kreyenberg H, Deak E, Pütsch K, Huenecke S, Amara C, Koller S, Rettinger E, Grez M, Koehl U, Latifi-Pupovci H, Henschler R, Tonn T, von Laer D, Klingebiel T, Bader P. Kuçi S, et al. Among authors: huenecke s. Haematologica. 2010 Apr;95(4):651-9. doi: 10.3324/haematol.2009.015065. Epub 2010 Feb 23. Haematologica. 2010. PMID: 20179086 Free PMC article.
Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
Bremm M, Huenecke S, Lehrnbecher T, Ponstingl E, Mueller R, Heinze A, Bug G, Quaiser A, Kapinsky M, Brehm C, Bader P, Schneider G, Klingebiel T, Koehl U. Bremm M, et al. Among authors: huenecke s. J Immunol Methods. 2011 Oct 28;373(1-2):36-44. doi: 10.1016/j.jim.2011.07.018. Epub 2011 Aug 3. J Immunol Methods. 2011. PMID: 21839739
IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.
Brehm C, Huenecke S, Quaiser A, Esser R, Bremm M, Kloess S, Soerensen J, Kreyenberg H, Seidl C, Becker PS, Mühl H, Klingebiel T, Bader P, Passweg JR, Schwabe D, Koehl U. Brehm C, et al. Among authors: huenecke s. PLoS One. 2011;6(11):e27351. doi: 10.1371/journal.pone.0027351. Epub 2011 Nov 9. PLoS One. 2011. PMID: 22096557 Free PMC article. Clinical Trial.
Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy.
Brehm C, Huenecke S, Esser R, Kloess S, Quaiser A, Betz S, Zimmermann O, Soerensen J, Passweg JR, Klingebiel T, Schwabe D, Bader P, Koehl U. Brehm C, et al. Among authors: huenecke s. Cancer Immunol Immunother. 2014 Aug;63(8):821-33. doi: 10.1007/s00262-014-1556-5. Epub 2014 May 8. Cancer Immunol Immunother. 2014. PMID: 24806448 Free PMC article. Clinical Trial.
SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy.
Rettinger E, Glatthaar A, Abhari BA, Oelsner S, Pfirrmann V, Huenecke S, Kuçi S, Kreyenberg H, Willasch AM, Klingebiel T, Fulda S, Bader P. Rettinger E, et al. Among authors: huenecke s. Front Pediatr. 2014 Jul 18;2:75. doi: 10.3389/fped.2014.00075. eCollection 2014. Front Pediatr. 2014. PMID: 25101252 Free PMC article.
53 results